Prolonged organ culture reduces the incidence of endothelial immune reactions – (Eye 30, 127 (January 2016))
Prolonged organ culture reduces the incidence of endothelial immune reactions Eye 30, 127 (January 2016). doi:10.1038/eye.2015.207 Authors: P Maier, S Heinzelmann, D Böhringer & T Reinhard
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience – (Eye 30, 133 (January 2016))
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience Eye 30, 133 (January 2016). doi:10.1038/eye.2015.209 Authors: F Ghanchi & C A Hazel
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study – (Eye 30, 139 (January 2016))
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study Eye 30, 139 (January 2016). doi:10.1038/eye.2015.199 Authors: C Bruè, A Pazzaglia, C Mariotti, M Reibaldi & A Giovannini
Complement pathway biomarkers and age-related macular degeneration – (Eye 30, 1 (January 2016))
Complement pathway biomarkers and age-related macular degeneration Eye 30, 1 (January 2016). doi:10.1038/eye.2015.203 Authors: M Gemenetzi & A J Lotery
Intraoperative optical coherence tomography: past, present, and future – (Eye Journal AOP)
Intraoperative optical coherence tomography: past, present, and future Eye advance online publication, December 18 2015. doi:10.1038/eye.2015.255 Author: J P Ehlers